3 ms·
Patients/doctors have much less incentive to pick the cheaper brand if the insurance company is forced to provide the expensive insulin for a low copay.
by cameldrv 3y ago
Patients/doctors have much less incentive to pick the cheaper brand if the insurance company is forced to provide the expensive insulin for a low copay.
- littlestymaar 3y agoWhat kind of insensitive are you talking about?
- stouset 3y agoIf a patient can get California-produced insulin for $30 or insulin produced by a for-profit pharmaceutical company for $35, many people won't bother to opt for the former. This, despite the latter containing significant hidden costs which are reflected in insurance premiums.
- littlestymaar 3y agoA 20% difference in cost ought to be enough of an incentive to make the consumer chose the nonprofit one especially since there shouldn't be any “bothering” involved. Also, insurers would have incentives to mandate the $30 version since it means lower cost on their side and they don't even have to reflect that in insurance premiums (which they don't since they're competing with each other).
- stouset 3y agoIf these were items you picked up off the shelf at the store with a displayed price, I’d agree with you. But 95% of the time, your doctor writes a scrip, your pharmacy fills the scrip, and if the sticker price is “reasonable” you pay and walk out.